Skip to main content
OpenTrials
Completed

NCT Number: NCT05375981

MAGNET Ingestion in Children

One year national observational surveillance study of children who ingest a magnetic foreign body

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 15 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Southampton Children's Hospital

Southampton, SO16 6YD, United Kingdom

About this study

The study aims to understand the incidence, management and outcomes of children who ingest a magnetic foreign body.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Magnetic foreign body ingestion
  • 16 years of age or less

Exclusion criteria

  • Non ingested foreign body

Treatment and study plan

Primary outcomes

  1. Incidence of MAGNETIC Foreign Body Ingestion

    Time frame: Over 1 year from May 1st 2022

Secondary outcomes

  1. Investigations and management of magnetic foreign body ingestion

    Time frame: Up to 28 days following ingestion

    What investigations and treatments these children had

  2. Outcomes of magnetic foreign body ingestion

    Time frame: Up to 28 days following ingestion

    What the outcomes were

Sponsors and collaborators

Lead sponsor

University Hospital Southampton NHS Foundation Trust

Other

Registry information

Official study title

Magnet Ingestion in Children: a Prospective Surveillance Study

Acronym: MAGNETIC

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
May 17, 2022
Registry last updated
Apr 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.